Cargando…

Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage

INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Alvarez, Ana, Sitges, Marta, Pinazo, María-Jesús, Regueiro-Cueva, Ander, Posada, Elizabeth, Poyatos, Silvia, Ortiz-Pérez, José Tomás, Heras, Magda, Azqueta, Manel, Gascon, Joaquim, Sanz, Ginés
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943653/
https://www.ncbi.nlm.nih.gov/pubmed/20877635
http://dx.doi.org/10.1371/journal.pntd.0000826
_version_ 1782187039407472640
author Garcia-Alvarez, Ana
Sitges, Marta
Pinazo, María-Jesús
Regueiro-Cueva, Ander
Posada, Elizabeth
Poyatos, Silvia
Ortiz-Pérez, José Tomás
Heras, Magda
Azqueta, Manel
Gascon, Joaquim
Sanz, Ginés
author_facet Garcia-Alvarez, Ana
Sitges, Marta
Pinazo, María-Jesús
Regueiro-Cueva, Ander
Posada, Elizabeth
Poyatos, Silvia
Ortiz-Pérez, José Tomás
Heras, Magda
Azqueta, Manel
Gascon, Joaquim
Sanz, Ginés
author_sort Garcia-Alvarez, Ana
collection PubMed
description INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based on nonspecific criteria with poor sensitivity. Early identification of patients with cardiac involvement is desirable, since early treatment may improve prognosis. This study aimed to assess the role of diastolic dysfunction, abnormal myocardial strain and elevated brain natriuretic peptide (BNP) in the early identification of cardiac involvement in Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS: Fifty-four patients divided into 3 groups—group 1 (undetermined form: positive serology without ECG or 2D-echocardiographic abnormalities; N = 32), group 2 (typical ECG abnormalities of Chagas disease but normal 2D-echocardiography; N = 14), and group 3 (regional wall motion abnormalities, left ventricular [LV] end-diastolic diameter >55 mm or LV ejection fraction <50% on echocardiography; N = 8)—and 44 control subjects were studied. Patients with significant non-cardiac diseases, other heart diseases and previous treatment with benznidazol were excluded. The median age was 37 (20–58) years; 40% were men. BNP levels, longitudinal and radial myocardial strain and LV diastolic dysfunction increased progressively from group 1 to 3 (p for trend <0.01). Abnormal BNP levels (>37 pg/ml) were noted in 0%, 13%, 29% and 63% in controls and groups 1 to 3, respectively. Half of patients in the undetermined form had impaired relaxation patterns, whereas half of patients with ECG abnormalities suggestive of Chagas cardiomyopathy had normal diastolic function. In group 1, BNP levels were statistically higher in patients with diastolic dysfunction as compared to those with normal diastolic function (27±26 vs. 11±8 pg/ml, p = 0.03). CONCLUSION/SIGNIFICANCE: In conclusion, the combination of diastolic function and BNP measurement adds important information that could help to better stratify patients with Chagas disease.
format Text
id pubmed-2943653
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29436532010-09-28 Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage Garcia-Alvarez, Ana Sitges, Marta Pinazo, María-Jesús Regueiro-Cueva, Ander Posada, Elizabeth Poyatos, Silvia Ortiz-Pérez, José Tomás Heras, Magda Azqueta, Manel Gascon, Joaquim Sanz, Ginés PLoS Negl Trop Dis Research Article INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based on nonspecific criteria with poor sensitivity. Early identification of patients with cardiac involvement is desirable, since early treatment may improve prognosis. This study aimed to assess the role of diastolic dysfunction, abnormal myocardial strain and elevated brain natriuretic peptide (BNP) in the early identification of cardiac involvement in Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS: Fifty-four patients divided into 3 groups—group 1 (undetermined form: positive serology without ECG or 2D-echocardiographic abnormalities; N = 32), group 2 (typical ECG abnormalities of Chagas disease but normal 2D-echocardiography; N = 14), and group 3 (regional wall motion abnormalities, left ventricular [LV] end-diastolic diameter >55 mm or LV ejection fraction <50% on echocardiography; N = 8)—and 44 control subjects were studied. Patients with significant non-cardiac diseases, other heart diseases and previous treatment with benznidazol were excluded. The median age was 37 (20–58) years; 40% were men. BNP levels, longitudinal and radial myocardial strain and LV diastolic dysfunction increased progressively from group 1 to 3 (p for trend <0.01). Abnormal BNP levels (>37 pg/ml) were noted in 0%, 13%, 29% and 63% in controls and groups 1 to 3, respectively. Half of patients in the undetermined form had impaired relaxation patterns, whereas half of patients with ECG abnormalities suggestive of Chagas cardiomyopathy had normal diastolic function. In group 1, BNP levels were statistically higher in patients with diastolic dysfunction as compared to those with normal diastolic function (27±26 vs. 11±8 pg/ml, p = 0.03). CONCLUSION/SIGNIFICANCE: In conclusion, the combination of diastolic function and BNP measurement adds important information that could help to better stratify patients with Chagas disease. Public Library of Science 2010-09-21 /pmc/articles/PMC2943653/ /pubmed/20877635 http://dx.doi.org/10.1371/journal.pntd.0000826 Text en Garcia-Alvarez et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Garcia-Alvarez, Ana
Sitges, Marta
Pinazo, María-Jesús
Regueiro-Cueva, Ander
Posada, Elizabeth
Poyatos, Silvia
Ortiz-Pérez, José Tomás
Heras, Magda
Azqueta, Manel
Gascon, Joaquim
Sanz, Ginés
Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title_full Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title_fullStr Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title_full_unstemmed Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title_short Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
title_sort chagas cardiomiopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943653/
https://www.ncbi.nlm.nih.gov/pubmed/20877635
http://dx.doi.org/10.1371/journal.pntd.0000826
work_keys_str_mv AT garciaalvarezana chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT sitgesmarta chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT pinazomariajesus chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT regueirocuevaander chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT posadaelizabeth chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT poyatossilvia chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT ortizperezjosetomas chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT herasmagda chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT azquetamanel chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT gasconjoaquim chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage
AT sanzgines chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage